Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.9
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 27203386
Chen CL, et al. (2016) Phosphorylation of E-cadherin at threonine 790 by protein kinase Cδ reduces β-catenin binding and suppresses the function of E-cadherin. Oncotarget 7, 37260-37276 27203386
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T790-p - CDH1 (human)
Modsite: TRNDVAPtLMsVPRy SwissProt Entrez-Gene
Orthologous residues
CDH1 (human): T790‑p, CDH1 (mouse): T792‑p, CDH1 (rat): T794‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  CHO (fibroblast), MDCK (epithelial)
Cellular systems studied:  cell lines
Species studied:  dog
Enzymes shown to modify site in vitro
Type Enzyme
KINASE PKCD (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKCD (human) pharmacological inhibitor of upstream enzyme, phospho-antibody, transfection of wild-type enzyme, activation of upstream enzyme
Downstream Regulation
Effect of modification (function):  activity, inhibited, molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
CTNNB1 (human) Disrupts pull-down assay
CBLL1 (human) Disrupts co-immunoprecipitation
Comments:  impairs homophilic interaction at cell-cell contacts

Y313-p - PKCD (human)
Modsite: ssEPVGIyQGFEKkT SwissProt Entrez-Gene
Orthologous residues
PKCD (human): Y313‑p, PKCD iso2 (human): Y313‑p, PKCD (mouse): Y311‑p, PKCD iso2 (mouse): Y311‑p, PKCD (rat): Y311‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  CHO (fibroblast), MDCK (epithelial)
Cellular systems studied:  cell lines
Species studied:  dog
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
HGF increase
dasatinib HGF inhibit treatment-induced increase
Downstream Regulation
Comments:  cell scattering